Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021 (Focus on Type, Design, Material both (Value & Volume) and Patent Landscape)

  • ID: 4289899
  • Report
  • Region: Global
  • BIS Research
1 of 6
The Global Market for Prefilled Syringes is Expected to Grow at a CAGR of 10.75% from 2017 to 2021

FEATURED COMPANIES

  • Baxter International
  • Eli Lilly
  • Medtronic Inc.
  • Pfizer
  • Stevanto Group
  • Unilife Corporation
  • MORE

Prefilled syringes have currently emerged as one of the fastest growing choices for unit dose medication since the pharmaceutical industry attempts to explore modern and more convenient drug delivery methods for application. With the evolution of prefilled syringes, pharmaceutical companies are able to efficiently minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their homes instead of hospitals. Prefilled syringes represent one of the fastest emergent segment among the injectable drug delivery devices market. The primarily factors associated with the use of prefilled syringes are ease of administration, condensed risk of cross contamination, a reduced amount of overfill and ease of treatment.

This research study includes an extensive analysis of the prefilled syringes market, by product type, material, design and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size and market volume, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of competitors within the global prefilled syringe market.

The following key questions have been addressed in the report:

  • What are the major market drivers, challenges and opportunities of the global prefilled syringes market?
  • How is the prefilled syringes market evolving during the forecast period?
  • What are the driving and restraining factors in the prefilled syringes market?
  • What are the market shares of the leading segments and sub-segments of the global prefilled syringes market in 2016 and 2023?
  • How will each segment of the prefilled syringes market grow over the forecast period and how much revenue will these account for in 2023?
  • How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
  • How will the industry evolve during the period between 2017 and 2023?
  • What are the key developmental strategies implemented in different types across all regions?
  • Which geographical region will lead the global prefilled syringes market by the end of the forecast period?
  • What are the market trends and key developments in this market?

The report includes the profiles of major players in the market that allows the readers to get an insight into the various industry trends.  Some of the leading companies in the market are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Baxter International
  • Eli Lilly
  • Medtronic Inc.
  • Pfizer
  • Stevanto Group
  • Unilife Corporation
  • MORE

Executive Summary

1 Research Scope and Methodology
1.1 Scope of the Report
1.2 Global GERD Therapy Market Segmentation
1.3 Key Objectives
1.4 Research Methodology
1.4.1  Data Triangulation
1.4.2  Secondary Sources
1.4.3 Primary Sources
1.4.4   Top-Down  Approach
1.4.5   Bottom-Up Approach
1.4.6  Assumptions and Limitations
1.4.7   Data and Prediction Modelling

2 Market Overview
2.1 Introduction
2.2 Advantages of Prefilled Syringes over traditional vial & syringe system
2.3 Manufacturing & Packaging Challenges of Prefilled Syringes
2.4 Benefits of prefilled syringes to the drug makers
2.5   Technology Trends in  Market
2.6   Legal Requirements and Regulations
2.7   Patent Analysis

3  Market Dynamics
3.1 Drivers
3.2 Challenges
3.3 Opportunities

4    Competitive Landscape
4.1 Key Market Development and Strategies
4.1.1 Mergers and Acquisition
4.1.2 Product Launch & Developments
4.1.3 Partnerships, Collaborations & Joint Ventures
4.1.4 Business Expansions and Contracts
4.2 Market Share Analysis
4.3 Industry Attractiveness

5 Industry Analysis
5.1 Regulatory Bodies and Associations
5.2 Patent Landscape

6 Global Prefilled Syringes by Type, 2016-2023 (Qualitative)
6.1 Overview
6.2 Conventional Prefilled Syringes
6.3 Safety Prefilled Syringes

7 Global Prefilled Syringes by Design, 2016-2023 (Qualitative)
7.1 Overview
7.2 Single-Chamber Prefilled Syringes
7.3 Dual-Chamber Prefilled Syringes
7.4 Customized Prefilled Syringes

8  Global Prefilled Syringes by Material Revenue ($Million) and Volume (Million Units), 2016-2023
8.1 Overview
8.2 Glass Prefilled Syringes
8.3 Plastic Prefilled Syringes

9 Global Prefilled Syringes Market by Region, Revenue ($Million) and Volume (Million Units), 2016-2023
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific (APAC)
9.5 Rest of the World (RoW)

10 Company Profiles
10.1 Baxter International
10.2 Becton Dickinson & Company
10.3 Bristol Myers Squibb
10.4 Eli Lilly
10.5 Gerresheimer
10.6 Medtronic Inc.
10.7 Nipro Corporation
10.8 Pfizer
10.9 SCHOTT AG
10.1 Stevanto Group
10.11 Terumo Corporation
10.12 Unilife Corporation
10.13 Vetter Pharmaceuticals GmBH
10.14 Weigao Group
10.15 West Pharmaceutical Services
10.16 Snapshot of Other Key Players

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Baxter International
  • Eli Lilly
  • Medtronic Inc.
  • Pfizer
  • Stevanto Group
  • Unilife Corporation
  • MORE

Prefilled syringes are increasingly witnessed as a primary choice for most of the high-end injectable drugs due to various advantages they offer over traditional packaging systems. A prefilled syringe is a single dose primary sterile container and delivery system that is filled aseptically with an injectable drug and sold for parenteral administration of drugs to patients. Anticoagulants, antivirals, anaphylaxis, hematopoietic, monoclonal antibodies and vaccines are the most commonly used therapeutic categories in the prefilled syringe format. Nowadays, with the help of prefilled syringes, pharmaceutical companies are able to minimize the drug waste and increase product life span, while the patients are able to self-administer injectable drugs at their home instead of the hospitals.

Despite the high paced competition in the global prefilled syringes market, future prospective growth is expected to be driven by favorable factors such as accurate drug dosing, negligible overfill requirements, no preservatives required in the formulation, increased assurance of sterility, ease of use and handling, time saving in emergency situations, and reduced material cost, among others, which are some of the major advantages provided by prefilled syringes. As a result, prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market.

The prefilled syringes market is growing exponentially worldwide due to the increase in prevalence of chronic diseases, growing demand and higher production of large molecule biologics and biosimilars, high penetration rate of self-injection devices and continuous advancement in prefilled syringes with the inclusion of autonomous inbuilt safety mechanisms. The global prefilled syringes market has been segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW).The European and North American markets are dominant in terms of market share, which is attributed to the presence of leading prefilled syringes and biological drug manufacturing players in both the regions.

Syringe manufacturers provide prefillable syringes in pre-sterilized or bulk forms to drug manufacturers for filling of various categories of injectable drugs including anticoagulants, vaccines, antivirals, hematopoietics, monoclonal antibodies and some other emergency drugs. The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.

Europe dominated the global market in 2016 with a share of XX%. Its market size by volume was estimated to be XX million units in 2016 and is projected to reach XX million units by 2021, registering a CAGR of XX% between 2017 and 2021. However, the Asia Pacific is estimated to show highest growth with a CAGR of XX% from 2017 to 2021.

The global glass prefilled syringe market value is accounted to be $XX million in 2016 and is projected to reach $XX million   by 2021, registering a CAGR of XX % between 2017 and 2021.

The increasing demand for safety plastic prefilled syringes due to its convenience and cost effectiveness have obligated companies to focus on new product developments and innovations. The most prominent opportunity for the industry players is market penetration in emerging markets such as Japan, China, Australia and India. Currently, the market is dominated by Europe due to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory standards regarding combination products and high manufacturing cost of prefilled syringes are hampering the growth of the market. Market penetration, establishment and outreach of major key players in the emerging markets, and increasing biologics and bio-similar in the market will serve as viable opportunities for the market players to enhance their business in the future.

The key players are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co, among others.

Note: Product cover images may vary from those shown
5 of 6
  • Baxter International
  • Becton Dickinson & Company
  • Bristol Myers Squibb
  • Eli Lilly
  • Gerresheimer
  • Medtronic Inc.
  • Nipro Corporation
  • Pfizer
  • SCHOTT AG
  • Stevanto Group
  • Terumo Corporation
  • Unilife Corporation
  • Vetter Pharmaceuticals GmBH
  • Weigao Group
  • West Pharmaceutical Services
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll